Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli
D.J. Dwyer, M.A. Kohanski, B. Hayete, and J.J. Collins Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli Mol. Syst. Biol. 3 2007 1 15
Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives
Y. Chai, M.L. Liu, K. Lv, L.S. Feng, S.J. Li, L.Y. Sun, S. Wang, and H.Y. Guo Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives Eur. J. Med. Chem. 46 2011 4267 4273
The fluoroquinolone as treatment for infections caused by gram-positive bacteria
M. Cruciani, and D. Bassetti The fluoroquinolone as treatment for infections caused by gram-positive bacteria J. Antimicrob. Chemother. 33 1994 403 417
Study on the mechanism of quinolone resistance in Pseudomonas aeruginosa
H.T. Xu, F.R. Tao, Y.Z. Liang, G.X. Wang, Y.L. Zou, Y.J. Hu, and X.Z. Zhang Study on the mechanism of quinolone resistance in Pseudomonas aeruginosa Chin. J. Infect. Chemother. 7 2007 92 95
Methyloxime-substituted aminopyrrolidine: A new surrogate for 7-basic group of quinolone
C.Y. Hong, Y.K. Kim, Y.H. Lee, and J.H. Kwak Methyloxime-substituted aminopyrrolidine: a new surrogate for 7-basic group of quinolone Bioorg. Med. Chem. Lett. 8 1998 221 226
Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-methylquinolones
V. Cecchetti, A. Fravolini, M.C. Lorenzini, O. Tabarrini, P. Terni, and T. Xin Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones J. Med. Chem. 39 1996 436 445
Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines
Z. Dang, Y.S. Yang, R.Y. Ji, and S.H. Zhang Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines Bioorg. Med. Chem. Lett. 17 2007 4523 4526
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: A cooperative drug-DNA binding model
L.L. Shen, L.A. Mitscher, P.N. Sharma, T.J. Odonnell, D.W.T. Chu, C.S. Cooper, T. Rosen, and A.G. Pernet Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model Biochemistry 28 1989 3886 3894
Ciprofloxacin: Review on developments in synthetic, analytical, and medicinal aspects
P.C. Sharma, A. Jain, S. Jain, R. Pahwa, and M.S. Yar Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects J. Enzyme Inhib. Med. Chem. 25 2010 557 589
Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2- oxoethyl] and N-[2-(5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones
A. Foroumadi, S. Emami, M. Mehni, M.H. Moshafi, and A. Shafiee Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[2-(5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones Bioorg. Med. Chem. Lett. 15 2005 4536 4539
Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol- 2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives
A. Foroumadi, S. Emami, A. Hassanzadeh, M. Rajaee, K. Sokhanvar, M.H. Moshafi, and A. Shafiee Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol- 2-yl)piperazinyl quinolone derivatives Bioorg. Med. Chem. Lett. 15 2005 4488 4492
Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2- yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen-2-yl]-2-(oxoimino)ethyl] piperazinyl quinolone derivatives
A. Foroumadi, M. Oboudiat, S. Emami, A. Karimollah, L. Saghaee, M.H. Moshafi, and A. Shafiee Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5-(methylthio)thiophen- 2-yl]-2-(oxoimino)ethyl] piperazinyl quinolone derivatives Bioorg. Med. Chem. 14 2006 3421 3427
Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety
A. Foroumadi, S. Ghodsi, S. Emami, S. Najjari, N. Samadi, M.A. Faramarzi, L. Beikmohammadi, F.H. Shirazi, and A. Shafiee Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl) piperazine moiety Bioorg. Med. Chem. Lett. 16 2006 3499 3503
Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-1,3,4 thiadiazole-2-sulfonyl)-piperazin-1-yl]fluoroquinolone derivatives
S. Talath, and A.K. Gadad Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-1,3,4 thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolone derivatives Eur. J. Med. Chem. 41 2006 918 924
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin
M.E. Erwin, R.N. Jones, M.S. Barrett, B.M. Briggs, and D.M. Johnson In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin Antimicrob. Agents Chemother. 35 1991 929 937
In vitro and in vivo activities of LB10522, a new catecholic cephalosporin
M.Y. Kim, J.I. Oh, K.S. Paek, Y.Z. Kim, I.C. Kim, and J.H. Kwak In vitro and in vivo activities of LB10522, a new catecholic cephalosporin Antimicrob. Agents Chemother. 40 1996 1825 1831
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin
M.E. Erwin, D. Varnam, and R.N. Jones In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin Diagn. Microbiol. Infect. Dis. 28 1997 93 100
Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N′-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines
Q. Guo, L.S. Feng, M.L. Liu, Y.B. Zhang, Y. Chai, K. Lv, H.Y. Guo, and L.Y. Han Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N′-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines Eur. J. Med. Chem. 45 2010 5498 5506
Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: Synthesis and antibacterial activity of 7-(4-(Aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4- oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304)
C.Y. Hong, Y.K. Kim, J.H. Chang, S.H. Kim, H. Choi, D.H. Nam, Y.Z. Kim, and J.H. Kwak Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(Aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304) J. Med. Chem. 40 1997 3584 3593
MICs were determined as described by the NCCLS see: National Committee for Clinical Laboratory Standards Wayne, PA M100-S11. The MIC was defined as the lowest concentration of each compound resulting in inhibition of visible growth of bacteria after incubation at 35 °C for 18 h
MICs were determined as described by the NCCLS see: National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing: 11th Informational Supplement vol. 21 2001 National Committee for Clinical Laboratory Standards Wayne, PA M100-S11. The MIC was defined as the lowest concentration of each compound resulting in inhibition of visible growth of bacteria after incubation at 35°C for 18 h
